Skip to main content
Log in

Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate clinical outcomes and their predictors in patients with venous malformation (VM) treated with foam sodium tetradecyl sulfate (STS) sclerotherapy.

Methods

We retrospectively evaluated clinical outcomes of foam STS sclerotherapy in 86 patients with 91 VMs to assess reduction in pain and mass after treatment. Univariate and multivariate analysis was performed to determine possible predictors of clinical outcome with foam STS sclerotherapy.

Results

A positive response of 49.5 % in pain reduction and 52.7 % in mass reduction was observed. The numerical rating scale (NRS) score improved from 4.36 ± 2.64 to 1.74 ± 1.57, and VM mass volume decreased to 41.7 ± 35.52 % of the initial size. On multivariate analysis, a high baseline NRS score (odds ratio: 1.12, 95 % confidence interval: 1.09–1.15) and VM location in the trunk versus the head and neck (odds ratio: 1.30, 95 % confidence interval: 1.00–1.69) were positive predictors of pain improvement. Minor complications occurred in 11 (12.1 %) patients and recurrence in 12 (13.2 %) patients.

Conclusions

Foam STS sclerotherapy is an effective treatment in venous malformation, with low complication risk. A high baseline NRS score and location in the trunk versus the head and neck were positive predictors in improvement of pain.

Key Points

Foam STS sclerotherapy is effective in VM, with low risk of complications.

Relief of pain tends to be dramatic in patients with severe pain.

Location of VM is a predictor of pain improvement.

The presence of a draining vein does not affect foam sclerotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

VM:

Venous malformation

VMs:

Venous malformations

STS:

Sodium tetradecyl sulfate

NRS:

Numerical rating scale

ADLs:

Activities of daily living

AVM:

Arteriovenous malformation

References

  1. Puig S, Aref H, Chigot V, Bonin B, Brunelle F (2003) Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 33:99–103

    Article  PubMed  Google Scholar 

  2. Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E (2001) Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 21:1519–1531

    Article  CAS  PubMed  Google Scholar 

  3. Puig S, Casati B, Staudenherz A, Paya K (2005) Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53:35–45

    Article  PubMed  Google Scholar 

  4. Lee BB, Baumgartner I, Berlien P et al (2015) Diagnosis and treatment of venous malformations. consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol 34:97–149

    CAS  PubMed  Google Scholar 

  5. Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin North Am 37:435–474

    Article  PubMed  Google Scholar 

  6. Legiehn GM, Heran MKS (2010) A step-by-step practical approach to imaging diagnosis and interventional radiologic therapy in vascular malformations. Semin Interv Radiol 27:209–231

    Article  Google Scholar 

  7. Shin BS, Do YS, Cho HS et al (2010) Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol 21:81–89

    Article  PubMed  Google Scholar 

  8. Yakes WF, Rossi P, Odink H (1996) How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 19:65–71

    Article  CAS  PubMed  Google Scholar 

  9. Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15:431–445

    Article  PubMed  Google Scholar 

  10. O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B (1997) Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 169:723–729

    Article  PubMed  Google Scholar 

  11. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 47:578–584

    Article  PubMed  Google Scholar 

  12. van der Vleuten CJ, Kater A, Wijnen MH, Schultze Kool LJ, Rovers MM (2014) Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol 37:977–989

    PubMed  Google Scholar 

  13. Albanese G, Kondo KL (2010) Pharmacology of sclerotherapy. Semin Interv Radiol 27:391–399

    Article  Google Scholar 

  14. Goyal M, Causer PA, Armstrong D (2002) Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 223:639–644

    Article  PubMed  Google Scholar 

  15. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104:1–11, discussion 12–15

    Article  CAS  PubMed  Google Scholar 

  16. Yun WS, Kim YW, Lee KB et al (2009) Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg 50:581–589

    Article  PubMed  Google Scholar 

  17. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158

    Article  CAS  PubMed  Google Scholar 

  18. McCaffery M, Pasero C (1999) Teaching patients to use a numerical pain-rating scale. Am J Nurs 99:22

    CAS  Google Scholar 

  19. Lee BB, Kim DI, Huh S et al (2001) New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33:764–772

    Article  CAS  PubMed  Google Scholar 

  20. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538

    Article  CAS  PubMed  Google Scholar 

  21. Tan KT, Kirby J, Rajan DK, Hayeems E, Beecroft JR, Simons ME (2007) Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol 18:343–351

    Article  PubMed  Google Scholar 

  22. Spence J, Krings T, terBrugge KG, da Costa LB, Agid R (2010) Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. Am J Neuroradiol 31:955–960

    Article  CAS  PubMed  Google Scholar 

  23. Hou R, Guo J, Hu K et al (2010) A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg 51:940–945

    Article  PubMed  Google Scholar 

  24. Leung AKC (2009) Venous malformation. In: Lang F (ed) Encyclopedia of molecular mechanisms of disease. Springer-Verlag, Berlin, pp 2185–2186

    Chapter  Google Scholar 

  25. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  CAS  PubMed  Google Scholar 

  26. Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD (2010) Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. AJR Am J Roentgenol 195:281–289

    Article  PubMed  Google Scholar 

  27. Zhao B, Schwartz LH, Larson SM (2009) Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers. J Nucl Med 50:239–249

    Article  PubMed  Google Scholar 

  28. Villoria GJ, Nakazawa M, Marks RA, Jarmakani JM (1976) The effect of left ventricular pressure or volume overload on ventricular dimension in children. Left ventricular volume determination from one or two ventricular dimensions. Circulation 54:969–974

    Article  CAS  PubMed  Google Scholar 

  29. Green D (1993) Mechanism of action of sclerotherapy. Semin Dermatol 12:88–97

    CAS  PubMed  Google Scholar 

  30. McAree B, Ikponmwosa A, Brockbank K, Abbott C, Homer-Vanniasinkam S, Gough MJ (2012) Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. Eur J Vasc Endovasc Surg 43:721–725

    Article  CAS  PubMed  Google Scholar 

  31. Goldman MP, Kaplan RP, Duffy DM (1987) Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 13:547–550

    Article  CAS  PubMed  Google Scholar 

  32. Yakes WF, Luethke JM, Parker SH et al (1990) Ethanol embolization of vascular malformations. Radiographics 10:787–796

    Article  CAS  PubMed  Google Scholar 

  33. Ikponmwosa A, Abbott C, Graham A, Homer-Vanniasinkam S, Gough MJ (2010) The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy. Eur J Vasc Endovasc Surg 39:366–371

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Siunna Baek for editing this manuscript.

The scientific guarantor of this publication is Young Soo Do. This study received funding from the Samsung Biomedical Research Institute (grant #SMX1150261). Institutional review board approval was obtained for the retrospective review of patients’ medical records and radiologic images, and for the questionnaires and interviews used to obtain data. Written informed consent was not required as this was a retrospective study. Methodology: retrospective cross-sectional study/observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Soo Do.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, H.S., Do, Y.S., Park, K.B. et al. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. Eur Radiol 26, 1301–1310 (2016). https://doi.org/10.1007/s00330-015-3931-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3931-9

Keywords

Navigation